197 related articles for article (PubMed ID: 37028606)
1. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective.
Hashemi M; Zandieh MA; Ziaolhagh S; Mojtabavi S; Sadi FH; Koohpar ZK; Ghanbarirad M; Haghighatfard A; Behroozaghdam M; Khorrami R; Nabavi N; Ren J; Reiter RJ; Salimimoghadam S; Rashidi M; Hushmandi K; Taheriazam A; Entezari M
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166714. PubMed ID: 37028606
[TBL] [Abstract][Full Text] [Related]
2. Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats.
Yang G; Li Q; Peng J; Jin L; Zhu X; Zheng D; Zhang Y; Wang R; Song Y; Hu W; Xie X
Eur J Pharmacol; 2021 Dec; 913():174629. PubMed ID: 34780751
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
Li B; Liu S; Miao L; Cai L
Exp Diabetes Res; 2012; 2012():216512. PubMed ID: 22645602
[TBL] [Abstract][Full Text] [Related]
4. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
6. P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.
Ma F; Wu J; Jiang Z; Huang W; Jia Y; Sun W; Wu H
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1272-1281. PubMed ID: 30959066
[TBL] [Abstract][Full Text] [Related]
7. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
[TBL] [Abstract][Full Text] [Related]
8. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathways.
Bao L; Li J; Zha D; Zhang L; Gao P; Yao T; Wu X
Int Immunopharmacol; 2018 Jan; 54():245-253. PubMed ID: 29161661
[TBL] [Abstract][Full Text] [Related]
9. Astaxanthin Promotes Nrf2/ARE Signaling to Inhibit HG-Induced Renal Fibrosis in GMCs.
Xie X; Chen Q; Tao J
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29621130
[TBL] [Abstract][Full Text] [Related]
10. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.
Jin Q; Liu T; Qiao Y; Liu D; Yang L; Mao H; Ma F; Wang Y; Peng L; Zhan Y
Front Immunol; 2023; 14():1185317. PubMed ID: 37545494
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.
Tanase DM; Gosav EM; Anton MI; Floria M; Seritean Isac PN; Hurjui LL; Tarniceriu CC; Costea CF; Ciocoiu M; Rezus C
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139066
[TBL] [Abstract][Full Text] [Related]
13. SP600125 suppresses
Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
16. Natural Nrf2 activators in diabetes.
Jiménez-Osorio AS; González-Reyes S; Pedraza-Chaverri J
Clin Chim Acta; 2015 Aug; 448():182-92. PubMed ID: 26165427
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
[TBL] [Abstract][Full Text] [Related]
18. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
[TBL] [Abstract][Full Text] [Related]
19. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?
Tan SM; de Haan JB
Redox Rep; 2014 May; 19(3):107-17. PubMed ID: 24559141
[TBL] [Abstract][Full Text] [Related]
20. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]